BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 25468717)

  • 1. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R
    Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs.
    Kotb DN; Mahdy WK; Mahmoud MS; Khairy RMM
    BMC Infect Dis; 2019 Nov; 19(1):979. PubMed ID: 31752702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.
    Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S
    Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.
    Yang H; Duan G; Zhu J; Zhang W; Xi Y; Fan Q
    Int J Antimicrob Agents; 2013 Aug; 42(2):173-7. PubMed ID: 23796894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
    Nam YS; Cho SY; Yang HY; Park KS; Jang JH; Kim YT; Jeong JW; Suh JT; Lee HJ
    Int J Antimicrob Agents; 2013 Feb; 41(2):126-9. PubMed ID: 23265914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.
    Azargun R; Soroush Barhaghi MH; Samadi Kafil H; Ahangar Oskouee M; Sadeghi V; Memar MY; Ghotaslou R
    J Glob Antimicrob Resist; 2019 Jun; 17():39-43. PubMed ID: 30445211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis.
    Piekarska K; Zacharczuk K; Wołkowicz T; Mokrzyś M; Wolaniuk N; Nowakowska M; Szempliński S; Dobruch J; Gierczyński R
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):81. PubMed ID: 34876123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of quinolone resistance mechanisms in Enterobacteriaceae isolated from companion animals in Europe (ComPath II study).
    de Jong A; Muggeo A; El Garch F; Moyaert H; de Champs C; Guillard T
    Vet Microbiol; 2018 Mar; 216():159-167. PubMed ID: 29519511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China.
    Zhan Q; Xu Y; Wang B; Yu J; Shen X; Liu L; Cao X; Guo Y; Yu F
    BMC Microbiol; 2021 Jun; 21(1):164. PubMed ID: 34078263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infection in Iran.
    Mirzaii M; Jamshidi S; Zamanzadeh M; Marashifard M; Malek Hosseini SAA; Haeili M; Jahanbin F; Mansouri F; Darban-Sarokhalil D; Khoramrooz SS
    J Glob Antimicrob Resist; 2018 Jun; 13():197-200. PubMed ID: 29747008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.
    Margaritis A; Galani I; Chatzikonstantinou M; Petrikkos G; Souli M
    J Med Microbiol; 2017 Mar; 66(3):266-275. PubMed ID: 27902429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Fluoroquinolone Resistance in Enterobacteriaceae Isolated from the Assiut University Hospitals, Egypt: A Comparative Study.
    Abdel-Rahim MH; El-Badawy O; Hadiya S; Daef EA; Suh SJ; Boothe DM; Aly SA
    Microb Drug Resist; 2019 May; 25(4):509-519. PubMed ID: 30457926
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciprofloxacin and nalidixic acid resistance of Salmonella spp. isolated from retail food in Poland.
    Mąka Ł; Maćkiw E; Stasiak M; Wołkowicz T; Kowalska J; Postupolski J; Popowska M
    Int J Food Microbiol; 2018 Jul; 276():1-4. PubMed ID: 29649749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period.
    Kim HB; Park CH; Kim CJ; Kim EC; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2009 Feb; 53(2):639-45. PubMed ID: 19064896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China.
    Yu F; Chen Q; Yu X; Pan J; Li Q; Yang L; Chen C; Zhuo C; Li X; Zhang X; Huang J; Wang L
    Int J Antimicrob Agents; 2011 Feb; 37(2):152-5. PubMed ID: 21163630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations in the gyrA and parC genes in Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from diseased food-producing animals.
    Liu BT; Liao XP; Yang SS; Wang XM; Li LL; Sun J; Yang YR; Fang LX; Li L; Zhao DH; Liu YH
    J Med Microbiol; 2012 Nov; 61(Pt 11):1591-1599. PubMed ID: 22878251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.